IL17A and cancer: GSEA revealed that the IL-17 signaling pathway, necroptosis, proteoglycans in cancer, and rheumatoid arthritis were the top 4 enriched pathways, among which proteoglycans in cancer were downregulated and the other three were upregulated in the high-score group (Fig. 7C).